GSK Expands Arexvy Approval for At-Risk Adults
LONDON, United Kingdom, May 20, 2026 GSK has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved...
adult immunization
Advertisement
RSV Vaccine Data Show Reduced Cardio-Respiratory Risks
Real-World Evidence Strengthens Adult Prevention Impact February 17, 2026 | London, United Kingdom GSK has released new real-world effectiveness...
European Commission Expands GSK’s RSV Vaccine Use to Adults 18+
London, United Kingdom, January 26, 2026 — GSK announced that the European Commission (EC) has approved an expanded indication...
Sanofi to Acquire Dynavax, Expanding Adult Vaccine Pipeline
Paris, France | December 24, 2025 — Sanofi announced that it has entered into a definitive agreement to acquire...
Advertisement
